輸入代號或公司名稱後按 Enter
1813

寶利徠

-0.10 (-0.88%)最後更新 2026-09-15
台灣 · 上櫃 · 生技醫療業
11.256成交張數48.91本益比0.76股價淨值比0.00%殖利率2026-09-15資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025304年增 -1.8%
毛利率2025-17.2%最新一期
營業利益率2025-41.8%最新一期
每股盈餘2025-1.03
會計項目走勢2016201720182019202020212022202320242025
銷貨收入淨額97.5%97.7%
其他營業收入淨額2.5%2.3%
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
銷貨成本119.3%117.2%
營業成本合計74.9%79.3%85.7%79.9%89.9%95.7%106.1%101.1%119.3%117.2%
營業毛利(毛損)25.1%20.7%14.3%20.1%10.1%4.3%-6.1%-1.1%-19.3%-17.2%
營業毛利(毛損)淨額25.1%20.7%14.3%20.1%10.1%4.3%-6.1%-1.1%-19.3%-17.2%
推銷費用8.5%9.5%8.3%9.3%7.8%4.8%6.5%6.8%7.8%6.1%
管理費用14.4%20.5%12.0%10.4%10.1%11.7%15.5%15.3%18.3%18.1%
研究發展費用1.6%1.3%1.2%1.5%1.3%1.0%0.8%0.6%1.2%0.4%
營業費用合計24.5%31.3%21.4%21.2%19.2%17.5%22.8%22.8%27.3%24.6%
營業利益(損失)0.6%-10.6%-7.1%-1.1%-9.1%-13.1%-28.9%-23.9%-46.6%-41.8%
利息收入0.2%0.1%0.7%2.0%1.9%2.0%
其他利益及損失淨額-2.7%-7.5%2.2%-1.1%-0.5%-4.0%12.6%1.1%8.1%0.0%
財務成本淨額0.2%0.5%0.4%0.7%1.0%0.9%1.4%2.4%2.8%3.0%
採用權益法認列之關聯企業及合資損益之份額淨額16.7%11.2%13.6%10.7%8.2%11.2%12.1%20.4%23.3%22.1%
營業外收入及支出合計14.1%3.9%16.2%9.5%7.0%6.4%24.1%21.1%30.4%21.1%
稅前淨利(淨損)14.7%-6.7%9.1%8.5%-2.1%-6.7%-4.8%-2.8%-16.2%-20.7%
所得稅費用(利益)合計0.9%-1.8%-0.4%0.7%-2.2%-1.1%-2.1%-1.6%-2.4%-2.9%
繼續營業單位本期淨利(淨損)13.8%-5.0%9.5%7.7%0.1%-5.6%-2.7%-1.2%-13.8%-17.8%
本期淨利(淨損)13.8%-5.0%9.5%7.7%0.1%-5.6%-2.7%-1.2%-13.8%-17.8%
確定福利計畫之再衡量數0.2%-0.1%-0.0%-0.0%0.1%-0.8%1.5%-0.2%0.1%0.3%
採用權益法認列之關聯企業及合資之其他綜合損益之份額-不重分類至損益之項目-0.0%-0.4%-0.1%-0.0%0.2%-0.1%0.6%0.3%0.3%0.1%
與不重分類之項目相關之所得稅0.0%-0.0%0.1%0.1%0.1%-0.9%0.3%-0.0%0.0%0.1%
不重分類至損益之項目:0.2%0.7%-3.9%1.7%0.1%0.4%0.4%
國外營運機構財務報表換算之兌換差額2.5%-4.0%0.9%-0.3%-0.9%-0.4%0.6%0.2%-2.1%2.0%
採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目-0.2%-0.5%-0.4%1.7%-0.1%1.5%-0.9%
與可能重分類之項目相關之所得稅-0.0%-0.2%0.0%-0.0%-0.1%-0.1%0.3%-0.0%0.3%-0.2%
後續可能重分類至損益之項目:-0.5%-1.3%-0.7%1.9%0.2%-0.8%1.3%
其他綜合損益(淨額)2.4%-5.5%1.6%-0.3%-0.6%-4.6%3.7%0.3%-0.5%1.7%
本期綜合損益總額16.2%-10.5%11.1%7.5%-0.5%-10.2%1.0%-0.9%-14.2%-16.1%
母公司業主(淨利∕損)15.7%0.5%13.9%9.8%-0.0%-2.9%1.9%3.1%-9.5%-15.8%
非控制權益(淨利∕損)-1.9%-5.5%-4.4%-2.1%0.1%-2.7%-4.6%-4.3%-4.3%-2.0%
母公司業主(綜合損益)16.9%-2.8%15.0%9.7%-0.2%-7.3%4.9%3.4%-9.7%-14.3%
非控制權益(綜合損益)-0.7%-7.7%-3.9%-2.2%-0.3%-2.9%-4.0%-4.3%-4.5%-1.8%
基本每股盈餘0.3%0.0%0.3%0.2%0.0%-0.1%0.0%0.1%-0.2%-0.3%
繼續營業單位淨利(淨損)0.0%0.0%0.0%0.0%0.0%-0.0%0.0%0.0%-0.0%-0.0%
稀釋每股盈餘0.3%0.0%0.3%0.2%0.0%-0.1%0.0%0.1%-0.2%-0.3%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益0.6%0.3%0.6%-4.0%0.0%0.0%
其他收入0.3%0.7%0.8%0.6%
採用權益法認列關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目-0.3%-1.1%0.3%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。